Outcome of Board Meeting 21.05.2026
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krebs Biochemicals reported a net loss of Rs 1,693.31 Lacs for FY 2026, though an improvement from the Rs 2,692.40 Lacs loss in FY 2025. Revenue from operations declined sharply to Rs 2,373.16 Lacs from Rs 4,331.19 Lacs in the prior year—a 45% revenue decline. The company has negative net worth of Rs 16,275.47 Lacs and negative other equity of Rs 18,431.53 Lacs. Total borrowings stand at Rs 22,483.82 Lacs with a negative debt-equity ratio of (1.38). The Vizag manufacturing unit has remained closed since February 2025 following an Andhra Pradesh Pollution Control Board order. Operating cash flow was negative at Rs 192.05 Lacs. The statutory auditors issued an unmodified opinion.
The company is in severe financial distress with negative net worth and declining revenues, raising substantial doubts about its ability to continue as a going concern despite the clean audit opinion.